|
|
Post by peppy on Mar 27, 2022 18:32:00 GMT -5
Insurance companies are about taking bets whether it's household, car, or pet insurance. They are betting that during the term of your policy, typically the next year, they will charge you more than they spend. The evidence is in the existence actuarial science which exists to let companies frame those bets. If you want to know how long the insurance company is looking ahead then look at the term of your insurance, and anything beyond that term is irrelevant to them. Could they collude, anti-trust aside? Yes, but why bother. Ultimately that bill will be picked up by Medicare and Medicaid rather than the insurer. You don't just need to change the SoC, you need to change the way the whole US health system is funded. As to changing the SoC, that's the same as it ever was - large scale clinical trials or go home! And there you go, all you have to read is the 2 above posts. Studies Published in journals/ Doctors Dosing Insurance I n addition people will keep trying if their insurance denies
It, they will not keep trying if they have a bad experience. Or, plenty of bad experiences on injectable rapid acting mealtime insulin. With few alternatives.  |
|
|
|
Post by sportsrancho on Mar 27, 2022 19:58:37 GMT -5
Of course but it is not our job to concentrate on others, we have to focus on our experiences. We believe we have the best mealtime insulin. When someone has a bad experience they tell 10 people. It’s the same in retail, customer service. Your Health care provider, their guidance and expertise and follow up make all the difference.
|
|
|
|
Post by buyitonsale on Mar 27, 2022 21:51:14 GMT -5
T2 diabetes is a carbohydrate toxicity syndrome.
It is not caused by a virus.
|
|
|
|
Post by sayhey24 on Mar 28, 2022 10:20:56 GMT -5
T2 diabetes is a carbohydrate toxicity syndrome. It is not caused by a virus. Until Covid that was a generally accepted theory except at Joslin in the lost studies. It reminds me of when stomach ulcers were the result of acidic foods. Maybe one of the few good things from covid is a renewed interest in the relationship between SARS and onset diabetes. Here are a number of covid studies. www.ncbi.nlm.nih.gov/pmc/articles/PMC7445123/Its appearing more like a virus affecting the beta cells and the resultant insulin after the infection. But, no one knows for sure. It does makes sense as we have a lot of obese people, eating lots of carbs and show no carbohydrate toxicity. What we do know from autopsy of non-diabetic obese is these people have grown large clumps of beta cells which produce more insulin for the body's needs. At the same time diabetic obese do not have this beta cell mass. Thats pretty strong evidence that something is going on with the beta cells. What we do know is early use of insulin can stop and reverse T2 diabetes even when intaking the same amount of carbohydrates. |
|
|
|
Post by sayhey24 on Mar 28, 2022 10:42:00 GMT -5
Aged once said that insurance companies do not take a long view because of the amount of time a particular insured person is with one provider or another. There wasn’t evidence to back it up, but my personal experience gave me the gut feeling Aged is right. That and there is a large insurance company in our area and I’ve talked with folks. Whatever else they may say, they’re not about managing health. They’re about managing costs; THEIR costs, not the patient’s. For Afrezza’s life-changing qualities to be recognized as saving limbs, lives, and most importantly, COSTS, it has to come from a consortium of insurers, or get one or two really big insurers to agree they’re ping-ponging patients amongst them and Afrezza can help the consortium. My guess is a discussion along those lines would be a unique first, and perhaps too close to violating anti-trust laws. I don’t expect that to happen. Stevil had it right, and some may remember that I’ve banged this gong more than once. And to borrow a phrase from James Carville, “It’s THE SAFETY, stupid!” Prove, in spectacularly convincing fashion, in a peer reviewed journal, that Afrezza’s safety with respect to managing TIR is unimpeachable and unattainable otherwise, and you will catch the attention of insulin-prescribers Didn't Dave Kendall present that study a few years back showing improved TIR with no increased hypo safety concerns? What we also know is its really hard getting a severe hypo as a T2 who is not on antiglycemics. Bill from VDex has one example in his papers demonstrating taking afrezza and not eating. Anyone can try it as afrezza is very repeatable. At this point its not a safety concern with afrezza. Its an SoC concern. Afrezza doesn't even get a mention in the T2 step protocol and its not because of safety. I also think Aged is correct in saying insurance companies are short sighted in costs as they have to show a profit on a quarterly basis. If I remember correctly Mike has spent a lot of time talking with Kaiser. I also think but not 100% sure Bill from VDex has also tried working with Kaiser. Until the SoC says use afrezza first the insurance companies will fully support prescribing metformin. If they get 3 or 4 years of just paying for metformin use, 4years is 16 quarters of revenue support. I think the result of all the talking is Mike's "Seeing is Believing" campaign. I do think for this campaign to work Mike needs a new SoC and the ADA is not going to help. Mike will either need to work with someone like the AACE or start a new organization. |
|
